A 59-year-old with HFrEF (EF 28%) on ARNI, beta-blocker, and MRA has stable BP 112/68 and eGFR 52 mL/min/1.73 m². Which additional therapy confers mor...

Question

A 59-year-old with HFrEF (EF 28%) on ARNI, beta-blocker, and MRA has stable BP 112/68 and eGFR 52 mL/min/1.73 m². Which additional therapy confers mortality and HF hospitalization benefit regardless of diabetes status?

Accepted Answer

Empagliflozin

Answer

Pioglitazone

Answer

Sitagliptin

Answer

Insulin glargine

Answer

Verapamil

us-abim MCQ (SBA): HFrEF-SGLT2 Inhibitors

A 59-year-old with HFrEF (EF 28%) on ARNI, beta-blocker, and MRA has stable BP 112/68 and eGFR 52 mL/min/1.73 m². Which additional therapy confers mortality and HF hospitalization benefit regardless of diabetes status?